New CPG: Asthma preventer treatment in adolescents 12 years +

The Asthma preventer treatment in adolescents 12 years + is a brand-new CPG providing new guidance on the anti-inflammatory reliever-based treatment regimen for adolescents with asthma. It has been reviewed by the CPG committee.


The Key points for the CPG are

  1. Any adolescent with asthma should be on a treatment regimen that includes an ICS. Prescribing SABA treatment (ie salbutamol) alone is no longer recommended
  2. For most adolescents with asthma, treatment can be started with as-needed combination of an ICS and a LABA
  3. Traditional treatment with SABA and inhaled ICS is also effective and should not be changed without consulting the adolescent’s care team or a senior clinician
  4. Treatment can be stepped up and down according to response. Never cease an adolescent’s ICS completely
  5. Always check inhaler technique and compliance before dose adjustment



Comments are closed.

Previous post Next post